查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1476328

2030 年微生物脂肪酶市場預測：按來源、形式、純度、功能、最終用戶和地區進行的全球分析

Microbial Lipase Market Forecasts to 2030 - Global Analysis By Source (Bacteria, Fungi, Yeast and Other Sources), Form (Liquid, Powder, Granular and Other Forms), Purity, Functionality, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球微生物脂肪酶市場規模為 6.5727 億美元，預計預測期內複合年成長率為 8.6%，到 ​​2030 年將達到 117098 萬美元。

微生物脂肪酶是由細菌、真菌等微生物產生的酶，在脂質代謝中扮演至關重要的角色。催化三酸甘油酯中酯鍵的水解，將其分解為甘油和脂肪酸。它可以增強風味和質地，並有助於脂肪的消化。由於其在較寬的 pH 值和溫度範圍內的穩定性，它在工業過程中受到重視。

人們對基於酶的解決方案的認知不斷增強

基於酵素的解決方案，尤其是微生物脂肪酶，為食品生產、生質燃料生產和製藥等製程提供了永續且環保的替代方案。隨著業界尋求更有效率、更環保的解決方案，對微生物脂肪酶的需求不斷增加。其以高特異性和高效率催化特定反應的能力，加上酶工程和生產技術的進步，進一步鞏固了其作為重要生物催化劑的地位，並正在推動市場擴張。

穩定性和保存期限有限

微生物脂肪酶的穩定性和保存期限有限是由於儲存期間和不利條件下可能發生的酶變性、蛋白水解和聚集等因素造成的。這些限制阻礙了它們在各種工業應用中的有效性和適用性，並影響產品品質和性能。因此，工業界可能會減少對微生物脂肪酶的依賴，並尋求替代酶源或具有更長保存期限和更高穩定性的合成替代品。

生物技術領域的拓展

微生物脂肪酶在生質燃料生產、藥物合成和清潔劑製造等生物技術領域中發揮重要作用。隨著生物技術的進步，由於微生物脂肪酶的多功能性、高效性和環境友善性，其需求預計將進一步增加。這一趨勢正在推動微生物脂肪酶開發的創新，提高其性能並擴大應用範圍，從而刺激生物技術領域的市場擴張。

技術挑戰

微生物脂肪酶的技術挑戰包括配方最佳化、製程條件微調和基材相容性。確保在各種工業條件下獲得最佳的酵素穩定性和活性是很困難的。此外，在不影響品質的情況下實現具有成本效益的生產方法仍然是一個挑戰。這些技術障礙阻礙了微生物脂肪酶的普及和應用，並影響了市場成長。

COVID-19 的影響

COVID-19 大流行對微生物脂肪酶市場產生了各種影響。對加工食品和清潔劑的需求增加增加了某些行業對微生物脂肪酶的需求，而供應鏈中斷、勞動力短缺和經濟不確定性給市場相關人員帶來了挑戰。此外，產業暫時關閉和消費者支出下降正在減緩市場成長。然而，市場正在表現出韌性，快速適應遠距工作，日益關注衛生產品，並加速支持市場復甦和未來成長前景的生物技術研究。

預計細菌細分市場在預測期內將是最大的細分市場

推測該細菌片段具有良好的生長。微生物脂肪酶是一種由細菌產生的酶，在各種工業應用中發揮重要作用。這些脂肪酶源自不同的細菌菌株，在不同條件下表現出顯著的基材特異性和穩定性，使其在生物技術、食品加工和醫學中具有價值。脂肪酶催化脂質中酯鍵的水解，促進乳酪成熟、清潔劑配方和生物柴油生產等過程。

預計製藥領域在預測期內複合年成長率最高

預計製藥公司領域在預測期內複合年成長率最高。微生物脂肪酶是由細菌和真菌等微生物產生的酶，在製藥公司中具有重要用途。脂肪酶在藥物製劑中的作用是協助藥物化合物的合成、促進藥物吸收、提高藥物穩定性。它對於生產對映體純藥物也至關重要，這可以確保療效並最大限度地減少副作用。

比最大的地區

預計亞太地區在預測期內將佔據最大的市場佔有率。快速的工業化、不斷擴大的食品和飲料行業以及對酵素產品不斷成長的需求正在推動市場擴張。此外，可支配收入的增加以及對更健康、更簡便食品的飲食偏好的改變正在推動該地區對微生物脂肪酶的需求。此外，政府積極支持生物技術研究和開發的措施也進一步推動了市場成長。

複合年成長率最高的地區：

預計北美在預測期內的複合年成長率最高。該地區先進的食品和飲料行業，加上對酶解決方案不斷成長的需求，是一個關鍵的驅動力。此外，技術進步、積極的研發活動和支持性法規結構也有助於市場擴張。由於重視永續性和創新，北美微生物脂肪酶市場預計在未來幾年將保持上升趨勢。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球微生物脂肪酶市場：依來源分類

  • 細菌
  • 菌類
  • 酵母菌
  • 其他來源

第6章全球微生物脂肪酶市場：依形式

  • 液體
  • 粉末
  • 顆粒狀
  • 其他格式

第7章全球微生物脂肪酶市場：依純度

  • 純脂肪酶
  • 工業級脂肪酶
  • 粗脂肪酶
  • 其他純度

第8章全球微生物脂肪酶市場：功能性別

  • 脂肪分解
  • 酯交換反應
  • 酯交換反應
  • 酯化反應
  • 其他功能

第9章全球微生物脂肪酶市場：依最終用戶分類

  • 食品加工公司
  • 製藥公司
  • 化妝品公司
  • 生質燃料製造商
  • 紡織品製造商
  • 其他最終用戶

第10章全球微生物脂肪酶市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Novozymes A/S
  • DuPont de Nemours, Inc.
  • DSM Nutritional Products
  • AB Enzymes GmbH
  • Amano Enzyme Inc.
  • Chr. Hansen Holding A/S
  • BASF SE
  • Associated British Foods PLC
  • Enzyme Development Corporation
  • Biocatalysts Limited
  • BioResource International Inc.
  • Novus International Inc.
  • Enzyme Solutions Limited
  • Koninklijke DSM NV
  • Kerry Group
  • Sunson Industry Group
Product Code: SMRC25874

According to Stratistics MRC, the Global Microbial Lipase Market is accounted for $657.27 million in 2023 and is expected to reach $1170.98 million by 2030 growing at a CAGR of 8.6% during the forecast period. Microbial lipase, an enzyme produced by microorganisms like bacteria and fungi, plays a pivotal role in lipid metabolism. It catalyzes the hydrolysis of ester bonds in triglycerides, breaking them down into glycerol and fatty acids. It enhances flavour and texture, and facilitates fat digestion. Its stability across a broad pH and temperature range makes it valuable in industrial processes.

Market Dynamics:

Driver:

Increased awareness about enzyme-based solutions

Enzyme-based solutions, particularly microbial lipases, offer sustainable and eco-friendly alternatives for processes like food production, biofuel manufacturing, and pharmaceuticals. As industries seek more efficient and environmentally friendly solutions, the demand for microbial lipases increases. Their ability to catalyze specific reactions with high specificity and efficiency, coupled with advancements in enzyme engineering and production technologies, further solidifies their position as essential biocatalysts, driving market expansion.

Restraint:

Limited stability and shelf-life

Limited stability and shelf-life in microbial lipases stem from factors such as enzyme denaturation, proteolysis, and aggregation, which can occur during storage or under unfavourable conditions. These limitations hinder their efficacy and suitability for various industrial applications, affecting product quality and performance. Consequently, industries may seek alternative enzyme sources or synthetic substitutes with longer shelf-life and greater stability, reducing reliance on microbial lipases.

Opportunity:

Expanding biotechnology sector

Microbial lipases play crucial roles in biotechnology applications such as biofuel production, pharmaceutical synthesis, and detergent manufacturing. As biotechnology continues to advance, the demand for microbial lipases is expected to rise further, driven by their versatility, efficiency, and eco-friendly nature. This trend fosters innovation in microbial lipase development, enhancing their performance and widening their application scope, thereby fueling market expansion within the biotechnology sector.

Threat:

Technical challenges

Technical challenges in microbial lipase include formulation optimization, process condition fine-tuning, and substrate compatibility. Ensuring optimal enzyme stability and activity across varied industrial conditions poses difficulties. Moreover, achieving cost-effective production methods without compromising quality remains a challenge. These technical hurdles hinder widespread adoption and application of microbial lipases, impacting market growth.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the microbial lipase market. While the increased demand for processed foods and detergents has driven up the need for microbial lipases in certain sectors, disruptions in the supply chain, workforce shortages, and economic uncertainties have posed challenges for market players. Additionally, the temporary closure of industries and reduced consumer spending has dampened market growth. However, the market has shown resilience, with rapid adaptation to remote work, increased focus on hygiene products, and accelerated research in biotechnology driving recovery and future growth prospects.

The bacteria segment is expected to be the largest during the forecast period

The bacteria segment is estimated to have a lucrative growth. Microbial lipases, enzymes produced by bacteria, play vital roles in various industrial applications. Derived from diverse bacterial strains, these lipases exhibit remarkable substrate specificity and stability under different conditions, making them invaluable in biotechnology, food processing, and pharmaceuticals. They catalyze the hydrolysis of ester bonds in lipids, facilitating processes like cheese ripening, detergent formulation, and biodiesel production.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical companies segment is anticipated to witness the highest CAGR growth during the forecast period. Microbial lipase, an enzyme produced by microorganisms like bacteria and fungi, finds crucial applications in pharmaceutical companies. Its role in drug formulation involves aiding in the synthesis of pharmaceutical compounds, enhancing drug absorption, and improving drug stability. They are essential for the production of enantiomerically pure drugs, thereby ensuring efficacy and minimizing side effects.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period. Rapid industrialization, expanding food and beverage sectors, and increasing demand for enzyme-based products are fueling market expansion. Additionally, rising disposable incomes and changing dietary preferences towards healthier and convenience foods are boosting the demand for microbial lipases in the region. Moreover, favourable government initiatives supporting biotechnology research and development are further propelling market growth.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period. The region's advanced food and beverage industry, coupled with a growing demand for enzyme-based solutions, is a primary driver. Furthermore, technological advancements, robust research and development activities, and a supportive regulatory framework are contributing to market expansion. With a focus on sustainability and innovation, the North American microbial lipase market is expected to continue its upward trajectory in the coming years.

Key players in the market

Some of the key players profiled in the Microbial Lipase Market include Novozymes A/S, DuPont de Nemours, Inc., DSM Nutritional Products, AB Enzymes GmbH, Amano Enzyme Inc., Chr. Hansen Holding A/S, BASF SE, Associated British Foods PLC, Enzyme Development Corporation, Biocatalysts Limited, BioResource International Inc., Novus International Inc., Enzyme Solutions Limited, Koninklijke DSM N.V., Kerry Group and Sunson Industry Group.

Key Developments:

In October 2023, BASF strengthens its enzyme technology for detergents and cleaners with the launch of a new enzymes' generation from its Lavergy(R) portfolio. With the latest expansion of its enzyme portfolio, BASF is raising the bar as an innovation leader and provider of key ingredients for the home care and I&I industry.

In May 2020, Biocatalysts Ltd launched new enzyme Lipomod(R) 767P, it is non-genetically modified microbial lipase preparation suitable for both the hydrolysis and esterification of oils and fats. Its broad spectrum pH profile means it can be used in applications across a wide range of substrate types. This product is an addition to Biocatalyst's extensive range of microbial enzymes, which have been developed to meet the growing demand for clean label products.

Sources Covered:

  • Bacteria
  • Fungi
  • Yeast
  • Other Sources

Forms Covered:

  • Liquid
  • Powder
  • Granular
  • Other Forms

Purities Covered:

  • Pure Lipase
  • Technical Grade Lipase
  • Crude Lipase
  • Other Purities

Functionalities Covered:

  • Lipolysis
  • Transesterification
  • Interesterification
  • Esterification
  • Other Functionalities

End Users Covered:

  • Food Processing Companies
  • Pharmaceutical Companies
  • Cosmetic Companies
  • Biofuel Manufacturers
  • Textile Manufacturers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microbial Lipase Market, By Source

  • 5.1 Introduction
  • 5.2 Bacteria
  • 5.3 Fungi
  • 5.4 Yeast
  • 5.5 Other Sources

6 Global Microbial Lipase Market, By Form

  • 6.1 Introduction
  • 6.2 Liquid
  • 6.3 Powder
  • 6.4 Granular
  • 6.5 Other Forms

7 Global Microbial Lipase Market, By Purity

  • 7.1 Introduction
  • 7.2 Pure Lipase
  • 7.3 Technical Grade Lipase
  • 7.4 Crude Lipase
  • 7.5 Other Purities

8 Global Microbial Lipase Market, By Functionality

  • 8.1 Introduction
  • 8.2 Lipolysis
  • 8.3 Transesterification
  • 8.4 Interesterification
  • 8.5 Esterification
  • 8.6 Other Functionalities

9 Global Microbial Lipase Market, By End User

  • 9.1 Introduction
  • 9.2 Food Processing Companies
  • 9.3 Pharmaceutical Companies
  • 9.4 Cosmetic Companies
  • 9.5 Biofuel Manufacturers
  • 9.6 Textile Manufacturers
  • 9.7 Other End Users

10 Global Microbial Lipase Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Novozymes A/S
  • 12.2 DuPont de Nemours, Inc.
  • 12.3 DSM Nutritional Products
  • 12.4 AB Enzymes GmbH
  • 12.5 Amano Enzyme Inc.
  • 12.6 Chr. Hansen Holding A/S
  • 12.7 BASF SE
  • 12.8 Associated British Foods PLC
  • 12.9 Enzyme Development Corporation
  • 12.10 Biocatalysts Limited
  • 12.11 BioResource International Inc.
  • 12.12 Novus International Inc.
  • 12.13 Enzyme Solutions Limited
  • 12.14 Koninklijke DSM N.V.
  • 12.15 Kerry Group
  • 12.16 Sunson Industry Group

List of Tables

  • Table 1 Global Microbial Lipase Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microbial Lipase Market Outlook, By Source (2021-2030) ($MN)
  • Table 3 Global Microbial Lipase Market Outlook, By Bacteria (2021-2030) ($MN)
  • Table 4 Global Microbial Lipase Market Outlook, By Fungi (2021-2030) ($MN)
  • Table 5 Global Microbial Lipase Market Outlook, By Yeast (2021-2030) ($MN)
  • Table 6 Global Microbial Lipase Market Outlook, By Other Sources (2021-2030) ($MN)
  • Table 7 Global Microbial Lipase Market Outlook, By Form (2021-2030) ($MN)
  • Table 8 Global Microbial Lipase Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 9 Global Microbial Lipase Market Outlook, By Powder (2021-2030) ($MN)
  • Table 10 Global Microbial Lipase Market Outlook, By Granular (2021-2030) ($MN)
  • Table 11 Global Microbial Lipase Market Outlook, By Other Forms (2021-2030) ($MN)
  • Table 12 Global Microbial Lipase Market Outlook, By Purity (2021-2030) ($MN)
  • Table 13 Global Microbial Lipase Market Outlook, By Pure Lipase (2021-2030) ($MN)
  • Table 14 Global Microbial Lipase Market Outlook, By Technical Grade Lipase (2021-2030) ($MN)
  • Table 15 Global Microbial Lipase Market Outlook, By Crude Lipase (2021-2030) ($MN)
  • Table 16 Global Microbial Lipase Market Outlook, By Other Purities (2021-2030) ($MN)
  • Table 17 Global Microbial Lipase Market Outlook, By Functionality (2021-2030) ($MN)
  • Table 18 Global Microbial Lipase Market Outlook, By Lipolysis (2021-2030) ($MN)
  • Table 19 Global Microbial Lipase Market Outlook, By Transesterification (2021-2030) ($MN)
  • Table 20 Global Microbial Lipase Market Outlook, By Interesterification (2021-2030) ($MN)
  • Table 21 Global Microbial Lipase Market Outlook, By Esterification (2021-2030) ($MN)
  • Table 22 Global Microbial Lipase Market Outlook, By Other Functionalities (2021-2030) ($MN)
  • Table 23 Global Microbial Lipase Market Outlook, By End User (2021-2030) ($MN)
  • Table 24 Global Microbial Lipase Market Outlook, By Food Processing Companies (2021-2030) ($MN)
  • Table 25 Global Microbial Lipase Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 26 Global Microbial Lipase Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 27 Global Microbial Lipase Market Outlook, By Biofuel Manufacturers (2021-2030) ($MN)
  • Table 28 Global Microbial Lipase Market Outlook, By Textile Manufacturers (2021-2030) ($MN)
  • Table 29 Global Microbial Lipase Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.